Carcinosarcoma: Clinical Trials

1 trial for Carcinosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Unknown 1

Follow Carcinosarcoma: new trials by email Literature Review of Carcinosarcoma trials Research Report on Carcinosarcoma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer
Carboplatin, Ifosfamide, Paclitaxel - Mixed Mesodermal (Mullerian) Tumor, Ovarian Carcinosarcoma
Phase 3UnknownGOG Foundation6372009-08-172021-09-30

Narrower conditions

Fallopian Tube Neoplasms (1)  ·  Ovarian Neoplasms (1)

Broader conditions

Adnexal Diseases (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Fallopian Tube Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)  ·  Genital Neoplasms, Female (1)  ·  Gonadal Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Complex and Mixed (1)  ·  Neoplasms, Connective and Soft Tissue (1)

Interventions

Carboplatin (1)  ·  Ifosfamide (1)  ·  Paclitaxel (1)  ·  Taxes (1)

Sponsors

GOG Foundation (1)

Countries

South Korea (1)  ·  United States (1)

Top investigators

Matthew A Powell (1)

Results publications

PMID 35007153

NIH funding

U10CA027469 (1), U10CA180868 (1)